Lv64
2220 积分 2024-07-22 加入
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia
1个月前
已关闭
Clinical application of base editing for treating β-thalassaemia
1个月前
已完结
In vivo CAR T cell engineering: design principles and open questions
1个月前
已完结
Enhancing CAR-NK cell efficacy in solid tumours
1个月前
已完结
Allogeneic B7-H3-targeted CAR-Vδ1T cell therapy in advanced solid tumors: A phase I study
1个月前
已完结
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia
1个月前
已关闭
Five‐Year Follow‐Up: Tandem CD19 / CD20 CAR T Therapy Enduring Impact on Refractory/Relapsed Non‐Hodgkin Lymphoma
1个月前
已完结
The Conflicting Role of Myeloid Cells in CAR-T Cell Therapy
1个月前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
1个月前
已完结
Progress in the development of cytokine armoured CAR T cells
1个月前
已完结
皖公网安备34019202002308
